Nivolumab is an anti-cancer medication used to treat various cancers, including melanoma and non-small cell lung cancer. It works by inhibiting the programmed death receptor-1 (PD-1), enhancing the immune response against cancer cells. Nivolumab's clinical significance lies in its ability to improve survival rates in patients with advanced cancers. In summary, Nivolumab is a crucial therapy for managing specific malignancies.
Nivolumab blocks PD-1, enhancing T-cell activation and promoting immune-mediated tumor destruction.
No published brands for this salt yet.